CSat Investment Advisory’s ResMed RMD Stock Holding History

CSat Investment Advisory’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$32K	Buy	165 +67	+68%	+$13.4K	0.03%	299
2020 Q4	$21K	Sell	98 -780	-89%	-$156K	0.02%	324
2020 Q3	$151K	Buy	878 +67	+8%	+$12.4K	0.01%	332
2020 Q2	$156K	Buy	811 +104	+15%	+$17K	0.02%	360
2020 Q1	$105K	Buy	707 +219	+45%	+$34.9K	0.02%	333
2019 Q4	$76K	Buy	488 +121	+33%	+$17.4K	0.02%	443
2019 Q3	$50K	Sell	367 -21	-5%	-$2.75K	0.02%	552
2019 Q2	$47K	Buy	388 +191	+97%	+$21.2K	0.02%	557
2019 Q1	$20K	Buy	197 +59	+43%	+$6.09K	0.01%	320
2018 Q4	$16K	Buy	138 +22	+19%	+$2.36K	0.01%	337
2018 Q3	$13K	Buy	116 +10	+9%	+$1.09K	0.01%	323
2018 Q2	$11K	Buy	+106	New	+$10.7K	0.01%	334

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CSat Investment Advisory's RMD Position: Q1 2021 in Review

CSat Investment Advisory increased its ResMed (RMD) stake by 68% in Q1 2021, buying an estimated $13.4K and bringing the position to 165 shares worth $32K. The position accounts for 0.03% of the portfolio, ranked #299.

CSat Investment Advisory first reported a position in RMD in Q2 2018 and has held it in 12 quarters since. The position peaked at $156K in Q2 2020. 663 funds tracked by Wall St. Rank hold RMD as of Q1 2021.

CSat Investment Advisory held 165 shares of ResMed worth $32K as of Q1 2021.
CSat Investment Advisory bought 67 ResMed shares in Q1 2021, an estimated $13.4K.
ResMed made up 0.03% of CSat Investment Advisory's portfolio in Q1 2021, its #299 holding.
CSat Investment Advisory first reported a position in ResMed in Q2 2018 and has held it in 12 quarters since.
CSat Investment Advisory's ResMed position peaked at $156K in Q2 2020.
663 funds tracked by Wall St. Rank held ResMed as of Q1 2021.

Based on CSat Investment Advisory's 13F filing for Q1 2021, filed 13 May 2021.